These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 3923812)
21. Cost-effectiveness of cancer chemotherapy: risks/benefit ratio--socio-economic and ethical considerations. Macdonald EA Cancer Treat Rev; 1987 Dec; 14(3-4):345-50. PubMed ID: 3125970 [No Abstract] [Full Text] [Related]
22. Conference explores impediments to meaningful treatment comparisons. Demand for cost-effectiveness data is impetus. Miller JL Am J Health Syst Pharm; 1995 Jun; 52(11):1140, 1145-8. PubMed ID: 7656102 [No Abstract] [Full Text] [Related]
23. [When is expensive pharmacotherapy good value for the money?]. Riesberg A; Velasco-Garrido M; Weinbrenner S; Gericke CA; Busse R Internist (Berl); 2004 Oct; 45(10):1189-95. PubMed ID: 15526176 [TBL] [Abstract][Full Text] [Related]
25. Researchers begin linking cost with performance to test new drugs' value. Hospitals; 1982 Apr; 56(7):54, 57. PubMed ID: 6800913 [No Abstract] [Full Text] [Related]
27. The use of pharmaceuticals in critical care. The importance of outcome prediction models. Clifton GD; Blumenschein K Pharmacoeconomics; 1995 May; 7(5):388-92. PubMed ID: 10155326 [No Abstract] [Full Text] [Related]
28. Using pharmaceutical cost analyses for decision making. U'Ren NA Hosp Cost Manag Account; 1997 Nov; 9(8):1-7. PubMed ID: 10178832 [No Abstract] [Full Text] [Related]
29. The price you pay for the drug not taken. McCarthy R Bus Health; 1998 Oct; 16(10):27-8, 30, 32-3. PubMed ID: 10185113 [No Abstract] [Full Text] [Related]
30. Cost effective drug budgets. Carter MG; Holman G BMJ; 1989 Nov; 299(6708):1166-7. PubMed ID: 2513042 [No Abstract] [Full Text] [Related]
31. Pharmacoeconomics: determining the value of drug therapy. Peterson C Healthplan; 1998; 39(3):44-50. PubMed ID: 10181751 [No Abstract] [Full Text] [Related]
32. How to pay for expensive drugs. Orme M BMJ; 1991 Sep; 303(6803):593-4. PubMed ID: 1932895 [No Abstract] [Full Text] [Related]
33. Pharmacoeconomic principles and methods: an introduction for hospital pharmacists. Sanchez LA Hosp Pharm; 1994 Aug; 29(8):774, 777-9. PubMed ID: 10135744 [No Abstract] [Full Text] [Related]
34. Strategies for reducing the drug bill. Sinclair B; Beaglehole R N Z Med J; 1989 Apr; 102(865):165-7. PubMed ID: 2704464 [No Abstract] [Full Text] [Related]
35. Will cost effectiveness analysis worsen the cost effectiveness of health care? Himmelstein DU; Woolhandler S; Bor DH Int J Health Serv; 1988; 18(1):1-9. PubMed ID: 3126156 [TBL] [Abstract][Full Text] [Related]
36. Children and mental health: how can the system be improved? England MJ; Cole RF Health Aff (Millwood); 1995; 14(3):131-8. PubMed ID: 7498886 [No Abstract] [Full Text] [Related]
37. A cost-benefit analysis of music therapy in a home hospice. Romo R; Gifford L Nurs Econ; 2007; 25(6):353-8. PubMed ID: 18240837 [TBL] [Abstract][Full Text] [Related]
38. Cost-effectiveness data on biologics needed. Sheridan C; Katsnelson A Nat Biotechnol; 2005 Mar; 23(3):272-3. PubMed ID: 15765069 [No Abstract] [Full Text] [Related]
39. Retiree medical plans--today's issues. Rysz CJ Top Health Care Financ; 1986; 12(4):52-60. PubMed ID: 3088768 [No Abstract] [Full Text] [Related]
40. Can we afford to treat head and neck cancer? Stell PM Clin Otolaryngol Allied Sci; 1987 Oct; 12(5):321-5. PubMed ID: 3123104 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]